CBChibuzor M. Babalola

Chibuzor M. Babalola

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chibuzor M. Babalola has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antenatal Screening for Sexually Transmitted Infections to Reduce Preterm Birth or Low Birthweight (Philani Ndiphile Study): A Randomized 3-Group Trial

    by Andrew Medina-Marino, Chibuzor M Babalola, Mandisa M Mdingi, Melissa L Wilson, Freedom Mukomana, Christina A Muzny, Christopher M Taylor, Ranjana M S Gigi, Hyunsul Jung, Nicola Low, et al.

    Background: Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis are predominantly asymptomatic curable sexually transmitted infections (STIs) associated with adverse birth outcomes. Whether antenatal STI screening improves birth outcomes remains uncertain. Methods: In this randomized trial (NCT04446611), pregnant women ≥18 years were assigned before 27 weeks' gestation to (1) screening and treatment for C. trachomatis, N. gonorrhoeae, and T. vaginalis at enrollment, with tests-of-cure (1-Time Screening); (2) screening and treatment at enrollment, repeated at 30–34 weeks (2-Time Screening); or (3) Standard-of-Care (syndromic management). The primary outcome was a composite of preterm birth (<37 weeks' gestation) or low birthweight (<2500 g); each component was evaluated individually as a secondary outcome. Results: Of 2247 enrolled, 1910 had live births. The composite outcome occurred in 22.9% of the 1-Time Screening (RR 0.99; 95% CI .81–1.21) and 20.6% of the 2-Time Screening groups (RR 0.89; 95% CI .72–1.09), compared with 23.2% of the Standard-of-Care group. Preterm birth occurred in 18.9% of the 1-Time Screening group (RR 1.00; 95% CI .80–1.26), 14.5% of the 2-Time Screening group (RR 0.77; 95% CI .60–0.99), and 18.8% of the Standard-of-Care group. Low birthweight occurred in 14.1% of the 1-Time Screening group (RR 1.10; 95% CI .83–1.46), 12.9% of the 2-Time Screening group (RR 1.01; 95% CI .76–1.35), and 12.8% of the Standard-of-Care group. Conclusions: Neither STI screening strategy reduced the primary composite outcome or low birthweight alone. The 2-Time Screening strategy reduced preterm birth by 23%.


  • Maternal Syphilis of Unknown Duration: Birth Outcomes in an Immediate Test-and-Treat Cohort often Receiving Fewer than Three Doses of Benzathine Penicillin G

    by Chibuzor M. Babalola, Remco P.H. Peters, Mandisa M. Mdingi, Christina A. Muzny, Christopher M. Taylor, Msindisi Gqirana, Andrew Medina-Marino, Jeffrey D Klausner

    In a South African antenatal cohort, an immediate test-and-treat model for syphilis of unknown duration showed that adverse birth outcomes—including stillbirth and preterm birth—were similar between women without syphilis and those treated with penicillin, regardless of completion of the three-dose regimen. Further studies are needed to evaluate optimal treatment strategies in pregnancy.

  • Open Access

    Mycoplasma genitalium infection and adverse pregnancy outcomes among pregnant women in South Africa: prospective cohort study

    by Ranjana Ms Gigi, Mandisa M Mdingi, Hyunsul Jung, Lydia Braunack-Mayer, Eric Mensah, Jean-Benoît Rossel, Chibuzor M Babalola, Christina A Muzny, Christopher M Taylor, Andrew Medina-Marino, et al.

    Background: Sexually transmitted infections (STIs) and vaginal dysbiosis during pregnancy are associated with adverse pregnancy outcomes. Mycoplasma genitalium is the most recent STI implicated but evidence remains limited. The objectives of this study were to investigate 1) the association between M. genitalium infection during pregnancy and gestational age at delivery, preterm birth, miscarriage or stillbirth, and low birth weight and 2) the interaction with vaginal dysbiosis. Methods: We conducted a prospective cohort study in East London, South Africa. We enrolled pregnant women at gestational age M. genitalium , Chlamydia trachomatis , Neisseria gonorrhoeae , Trichomonas vaginalis , other genital mycoplasmas and Candida spp. We defined vaginal dysbiosis using Gram-stain criteria as a Nugent score 4-10. We used quantile regression to compare the outcome in women with and without M. genitalium across the gestational age distribution, adjusting for prespecified sociodemographic and clinical characteristics and co-occurring organisms. Results: From April 1, 2021 to August 29, 2023, we enrolled 603 women, followed up 584 and obtained pregnancy outcomes for 560 (93%). Median age was 28 years (interquartile range, IQR 24, 33) and 27% of women were living with HIV. M. genitalium was detected in 44/584 (8%, 95% CI 6, 10%) and vaginal dysbiosis in 375/584 (64%) of women. Median gestational age at delivery was 39 weeks +0 days (IQR 37+4, 40+1) in women with and 39 weeks +0 days (37+4, 40+0) in those without M. genitalium . In multivariable models, associations were not observed for any adverse birth outcomes. There was no interaction between M. genitalium and vaginal dysbiosis. Discussion: M. genitalium in pregnancy was not associated with earlier gestational age at delivery or with other adverse birth outcomes. These findings do not support routine testing and treatment for M. genitalium in pregnancy.

  • Open Access

    Cost-effectiveness and cost-utility of antenatal sexually transmitted infection screening to reduce preterm birth and low birthweight in South Africa

    by Elise Smith, Chibuzor M Babalola, Andrew Medina-Marino, Mandisa Mdingi, Freedom Mukomana, Nicola Low, Amarech Obse, Remco P.H. Peters, Jeffrey D Klausner, Susan Cleary, et al.

    Background: Curable sexually transmitted infections (STIs) are associated with adverse birth outcomes, yet little cost-effectiveness evidence guides antenatal STI screening policy in high-burden settings. We conducted a cost-effectiveness and cost-utility analysis of the Philani Ndiphile trial in South Africa, comparing One-Time and Two-Time antenatal screening for C. trachomatis, N. gonorrhoeae, and T. vaginalis with standard syndromic management. Methods: A decision-analytic model from the provider perspective simulated costs and outcomes for pregnant women and infants. Costs included diagnostics, treatment, and neonatal hospitalisation for a primary composite outcome of preterm birth and/or low birthweight and its components (secondary trial outcomes). Modelled outcomes included incremental cost (US$) per composite (preterm birth and/or low birthweight) case, per component case and per disability-adjusted life year (DALY) averted. The analysis captured infant outcomes in the first year. Univariate and probabilistic sensitivity analyses were conducted to assess parameter uncertainty and robustness of results. Results: Screening for C. trachomatis, N. gonorrhoeae, and T. vaginalis twice during pregnancy was not cost-effective for preventing the primary composite outcome, nor for preventing low birthweight alone. However, two-time screening was cost-saving for preventing preterm birth alone, averting more DALYs and thereby yielding better health outcomes while reducing healthcare costs compared with syndromic management. One-time screening was not cost-effective for preventing any outcome. Conclusions: Repeat antenatal screening for C. trachomatis, N. gonorrhoeae , and T. vaginalis has the potential to prevent preterm births while reducing healthcare costs in high-burden settings. These findings support further research to confirm the clinical effectiveness of repeat screening and to evaluate longer-term health and economic impacts.

  • Open Access

    Antenatal Screening for Sexually Transmitted Infections to Reduce Preterm Birth or Low Birthweight (Philani Ndiphile Study): A Randomized Three-Group Trial

    by Andrew Medina-Marino, Chibuzor M Babalola, Mandisa M Mdingi, Melissa L. Wilson, Freedom Mukomana, Christina A Muzny, Christopher M Taylor, Ranjana Ms Gigi, Hyunsul Jung, Nicola Low, et al.

    SUMMARY: Background: Chlamydia trachomatis , Neisseria gonorrhoeae , and Trichomonas vaginalis are curable sexually transmitted infections (STIs) associated with adverse birth outcomes. Most infections are asymptomatic. Whether antenatal STI screening improves birth outcomes remains uncertain. Methods: In a randomized three-group trial in South Africa, pregnant women aged 18 years or older were assigned before 27 weeks’ gestation to: (1) screening and treatment for Chlamydia trachomatis, Neisseria gonorrhoeae , and Trichomonas vaginalis at enrollment, with tests-of-cure (One-Time Screening); (2) screening and treatment at enrollment, repeated at 30 to 34 weeks (Two-Time Screening); or (3) Standard-of-Care (Syndromic management). The primary outcome was a composite of preterm birth (Chlamydia trachomatis , Neisseria gonorrhoeae , and Trichomonas vaginalis reduced the primary composite outcome of preterm birth or low birthweight, or low birthweight alone. The Two-Time antenatal STI screening strategy, however, reduced preterm birth by 23%.


  • Open Access

    Implementation of point-of-care screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among pregnant women in South Africa: a mixed-methods process evaluation of the Philani Ndiphile trial

    by Natalie Grace Shaetonhodi, Lindsey De Vos, Chibuzor Babalola, Alex de Voux, Dvora Joseph Davey, Mandisa M Mdingi, Remco P.H. Peters, Jeffrey D. Klausner, Andrew Medina-Marino

    Background: Curable sexually transmitted infections (STIs), including Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, remain highly prevalent among pregnant women in South Africa. Despite poor diagnostic performance in pregnancy, syndromic management remains standard care. Point-of-care (POC) screening enables aetiological diagnosis and same-visit treatment but is not yet included in national guidelines. We conducted a mixed-methods process evaluation to examine determinants of antenatal POC STI screening implementation in public facilities. Methods: This evaluation was embedded within the three-arm Philani Ndiphile randomized trial (March 2021-February 2025) across four public clinics in the Eastern Cape. Screening used a near-POC, electricity-dependent nucleic acid amplification test with a 90-minute turnaround time. Reach, Adoption, Implementation, and Maintenance were assessed using the RE-AIM framework. Quantitative indicators included uptake of screening, treatment, and follow-up attendance. Qualitative data included in-depth interviews with 20 pregnant women and five focus group discussions with 21 research staff and government healthcare workers. The Consolidated Framework for Implementation Research guided qualitative analysis. Findings were integrated using narrative weaving. Results: Screening uptake was high (99.0%), with treatment coverage of 95.2% at baseline and 93.5% at repeat screening. Same-day treatment was lower (50.7% and 69.8%) and varied substantially by facility, reflecting operational constraints including turnaround time, patient volume, infrastructure, and electricity. Attendance was higher when screening was integrated into routine ANC. Women valued screening for infant health, while providers recognised advantages over syndromic management but highlighted workforce, resource, and maintenance constraints. Socioeconomic factors, including transport costs, hunger, and work commitments, influenced retention and waiting. Conclusions: Antenatal POC STI screening was acceptable and achieved high treatment coverage in a research setting. However, same-day treatment was constrained by operational requirements of the testing platform. Scale-up will require workflow integration, strengthened health system capacity, and faster diagnostics suited to routine antenatal care.

  • Open Access

    Educational Attainment and HIV Prevalence by Age Among Pregnant Women in South Africa

    by Chibuzor M. Babalola, Kalpana Gopalkrishnan, Mandisa M. Mdingi, Freedom Mukomana, Msindisi Gqirana, Christina A. Muzny, Christopher M. Taylor, Remco P. H. Peters, Andrew Medina-Marino, Jeffrey D. Klausner

    We examined the association between educational attainment and HIV positivity among pregnant women in a high HIV-prevalence setting and assessed how this relationship varies by age to inform targeted prevention strategies. This cross-sectional study included 2003 pregnant women aged 21–44 years attending their first antenatal visit (<27 weeks’ gestation) at four public health facilities in East London, South Africa, between March 2021 and May 2024. Educational attainment was categorized as pre–high school (< grade 10), high school (grades 10–12), diploma (post–high school), or degree (associate’s or bachelor’s). Age was categorized into four groups (21–24, 25–29, 30–34, and 35–44 years). HIV status was determined through routine antenatal testing. We used logistic regression to assess associations between educational attainment and HIV positivity, adjusting for age, partner’s HIV status, and participant sexually transmitted infection (STI) status. Overall HIV prevalence was 31.0% (95% CI, 28.9%–33.0%). Compared with women with less than a high school education, the odds of HIV infection were lower among women who attained high school education (adjusted odds ratio [AOR], 0.59; 95% CI, 0.40–0.87), a diploma (AOR, 0.40; 95% CI, 0.24–0.67), or a degree (AOR, 0.21; 95% CI, 0.09–0.43). However, this inverse association was not observed among women aged 35–44 years. In conclusion, higher educational attainment was associated with lower HIV prevalence among pregnant women, but this protective association diminished with increasing age. HIV prevention strategies should account for both socioeconomic factors and age-related interpersonal dynamics influencing HIV vulnerability.

  • Open Access

    Expanding Horizons in Syphilis Treatment: Challenges, Advances, and Opportunities for Alternative Antibiotics

    by Diana D. Villarreal, Chibuzor M. Babalola

    Purpose of Review: This review examines the growing need for alternative technologies to address the resurgence of syphilis, particularly its congenital and late-stage manifestations. It explores current treatment paradigms, highlights the limitations of penicillin, and evaluates emerging evidence on new therapies and diagnostics to inform future strategies. Recent Findings: Recent breakthroughs in Treponema pallidum culture techniques have enabled antibiotic susceptibility testing, expanding knowledge on both established and emerging treatment options. Alternatives like ceftriaxone, doxycycline, cefixime, and dalbavancin show promise, with other candidates in trials, though evidence is limited beyond early-stage syphilis. Shortened penicillin regimens also challenge historical assumptions about treatment duration. Advanced molecular diagnostics may complement currently limited serologic monitoring to improve evaluations in healthcare and research. Summary: While penicillin remains effective, its limitations necessitate alternatives. Emerging antibiotics and improved diagnostics offer opportunities to simplify treatment and enhance care. Future robust trials should validate new treatments, refine dosing strategies, and integrate innovative diagnostics, particularly including underserved and vulnerable populations.


  • Open Access

    Does a waiting room increase same-day treatment for sexually transmitted infections among pregnant women? A quality improvement study at South African primary healthcare facilities

    by Ranjana M.S. Gigi, Mandisa M. Mdingi, Lukas Bütikofer, Chibuzor M. Babalola, Jeffrey D. Klausner, Andrew Medina-Marino, Christina A. Muzny, Christopher M. Taylor, Janneke H.H.M. van de Wijgert, Remco P.H. Peters, et al.

    Background Same-day testing and treatment of curable sexually transmitted infections (STI) is a strategy to reduce infection duration and onward transmission. South African primary healthcare facilities often lack sufficient waiting spaces. This study aimed to assess the proportion of, and factors influencing, pregnant women waiting for on-site STI test results before and after the installation of clinic-based waiting rooms. Methods We conducted an observational quality improvement study at 5 public primary healthcare facilities in South Africa from March 2021 to May 2023. The intervention was the installation of a waiting room in two clinics. Three clinics were used as comparators: two already had a waiting room in an existing building and one had access to a shared waiting area. The outcome was the percentage of women who waited for their STI test results. We conducted univariable and multivariable analyses and report marginal risk differences (with 95% confidence intervals, CI) of the proportions of women who waited for results. A subset of women answered structured questions about factors influencing their decision to wait for results. Results We analysed data from 624 women across the 5 facilities. Overall, 36% (95% CI 31, 40) waited for their test results (range 7% to 89%). In the two intervention clinics, 17% (95% CI 11, 24) waited for results before the introduction of a waiting room and 10% (95% CI 5, 18) after (crude absolute difference -7% (95% CI -16, +3), adjusted difference, -6% (95% CI -17, +5)). The percentages of pregnant women waiting for sexually transmitted infection test results were higher throughout the study period in 2 clinics which always had a dedicated waiting room than in 2 clinics where a waiting room was installed, or in 1 clinic, which only had access to a shared waiting area. Most women reported before testing that they did not intend to wait and none of the suggested factors would change their decision. Conclusions Introduction of a waiting room did not increase the proportion of women who waited for their results in this observational study. Future studies should investigate infrastructure, individual and test-based factors that affect same-day STI testing and treatment.


  • Open Access

    Antenatal Screening for Sexually Transmitted Infections to Improve Maternal and Newborn Outcomes: An Update From 11 Low- and Middle-Income Countries

    by Chibuzor M. Babalola, Jeffrey D. Klausner

    An abstract is unavailable. This article is available as a PDF only.